Using economic and social data to improve veterinary vaccine development: Learning lessons from human vaccinology

Simple item page
cg.authorship.typesCGIAR and advanced research instituteen
cg.contributor.affiliationUniversity of Liverpoolen
cg.contributor.affiliationInternational Livestock Research Instituteen
cg.contributor.crpAgriculture for Nutrition and Health
cg.contributor.donorBiotechnology and Biological Sciences Research Council, United Kingdomen
cg.contributor.donorDepartment for International Development, United Kingdomen
cg.contributor.donorEconomic and Social Research Council, United Kingdomen
cg.contributor.donorNatural Environment Research Council, United Kingdomen
cg.contributor.donorDefence Science and Technology Laboratory, United Kingdomen
cg.contributor.donorEuropean Unionen
cg.creator.identifierLian Thomas: 0000-0001-8447-1210
cg.creator.identifierJonathan Rushton: 0000-0001-5450-4202
cg.howPublishedFormally Publisheden
cg.identifier.doihttps://doi.org/10.1016/j.vaccine.2018.10.044en
cg.isijournalISI Journalen
cg.issn0264-410Xen
cg.issue30en
cg.journalVaccineen
cg.reviewStatusPeer Reviewen
cg.subject.ilriDATAen
cg.subject.ilriRESEARCHen
cg.subject.ilriVACCINESen
cg.volume37en
dc.contributor.authorThomas, Lian F.en
dc.contributor.authorBellet, C.en
dc.contributor.authorRushton, Jonathanen
dc.date.accessioned2018-10-19T10:57:34Zen
dc.date.available2018-10-19T10:57:34Zen
dc.identifier.urihttps://hdl.handle.net/10568/97680
dc.titleUsing economic and social data to improve veterinary vaccine development: Learning lessons from human vaccinologyen
dcterms.abstractThe drivers of vaccine development are many and varied. They include, for example, recognition of the burden of a vaccine-targeted disease, prioritisation of the multiple problems associated with a disease, consideration of the differing socio-economic situations under which vaccines are used, the influence of advocacy groups, and assessment of the feasibility of large-scale vaccine manufacture and distribution. In the field of human health, data-driven development of vaccines is becoming increasingly common through the availability of reliable information on the Global Burden of Disease (GBD) and stringent evaluations of vaccination programmes utilising empirical data on costing and effectiveness, and standardised cost-effectiveness thresholds. The data generated from such analyses allow policymakers, implementing partners, industries and researchers to make decisions based on the best, and most contextually relevant, available evidence. In this paper, we wish to explore the current use of economic and social data for the development of veterinary vaccines. Through comparison with the development of human vaccines, we will look for opportunities in animal health sciences to better integrate socio-economic data and analyses into the process of veterinary vaccine selection, development, and field implementation. We believe that more robust animal health impact assessments could add value to veterinary vaccine development by improving resource allocation and animal disease management.en
dcterms.accessRightsOpen Access
dcterms.audienceScientistsen
dcterms.bibliographicCitationThomas, L.F., Bellet, C. and Rushton J. 2019. Using economic and social data to improve veterinary vaccine development: Learning lessons from human vaccinology. Vaccine 37(30): 3974–3980.en
dcterms.extentp. 3974-3980en
dcterms.issued2019-07
dcterms.languageen
dcterms.licenseCC-BY-4.0
dcterms.publisherElsevieren
dcterms.subjectdisease controlen
dcterms.subjectvaccinesen
dcterms.subjectdataen
dcterms.subjectresearchen
dcterms.typeJournal Article

Files

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

ILRI articles in journals
CRP A4NH outputs
ILRI animal and human health program outputs (2017–2024)